Zkusit zdarma
Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

ESPR
Cena:
$ 3.13
0.00 (0.00%)
Valuace
70
Růst
45
Zdraví
63
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

16:30 14-05-2026

ANN ARBOR, Mich., May 14, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on M...

ESPR Stock Surges 44% in a Month: Here's What You Need to Know

ESPR Stock Surges 44% in a Month: Here's What You Need to Know

11:46 14-05-2026

Esperion shares jump nearly 44% in a month. The primary catalyst was Archimed's agreement to acquire...

Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR

Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR

11:48 04-05-2026

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, ...

Shareholder Alert: Ademi LLP investigates whether Esperion Therapeutics, Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Esperion Therapeutics, Inc. is obtaining a Fair Price for Public Shareholders

11:30 01-05-2026

MILWAUKEE, May 1, 2026 /PRNewswire/ -- Ademi LLP is investigating Esperion (NASDAQ: ESPR) for possib...

ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

9:41 01-05-2026

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale ...

Archimed to take Esperion Therapeutics private in $1.1 billion deal

Archimed to take Esperion Therapeutics private in $1.1 billion deal

7:37 01-05-2026

Investment firm Archimed will ‌take Esperion Therapeutics private for up to $1.1 billion, the comp...

Esperion to be Acquired by ARCHIMED

Esperion to be Acquired by ARCHIMED

7:00 01-05-2026

Esperion shareholders to receive $3. 16 per share in cash at closing, plus the right to participate ...

Esperion to Report First Quarter 2026 Financial Results on May 7

Esperion to Report First Quarter 2026 Financial Results on May 7

8:00 23-04-2026

ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will...

Esperion Therapeutics Highlights 38% Revenue Growth, Enbumyst Launch Plan at Needham Conference

Esperion Therapeutics Highlights 38% Revenue Growth, Enbumyst Launch Plan at Needham Conference

3:35 15-04-2026

Esperion Therapeutics (NASDAQ: ESPR) outlined its commercial progress and strategic priorities at Ne...

Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?

Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?

12:31 09-04-2026

Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?...

Esperion Therapeutics, Inc. $ESPR Shares Purchased by JPMorgan Chase & Co.

Esperion Therapeutics, Inc. $ESPR Shares Purchased by JPMorgan Chase & Co.

4:59 06-04-2026

JPMorgan Chase and Co. raised its stake in Esperion Therapeutics, Inc. (NASDAQ: ESPR) by 68.4% in th...

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

16:05 02-04-2026

NEW YORK and ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Athyrium Capital Management, LP an...

Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference

Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference

2:34 17-03-2026

Executives from Esperion Therapeutics (NASDAQ: ESPR) highlighted accelerating revenue growth, plans ...

Brokerages Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) Target Price at $8.25

Brokerages Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) Target Price at $8.25

1:44 16-03-2026

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR - Get Free Report) have been assigned an average...

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

12:50 11-03-2026

Esperion Therapeutics' Q4 revenues surge 144% to $168.4M but EPS of 22 cents misses estimates. Share...

Esperion Therapeutics, Inc. (ESPR) Q4 2025 Earnings Call Transcript

Esperion Therapeutics, Inc. (ESPR) Q4 2025 Earnings Call Transcript

10:40 10-03-2026

Esperion Therapeutics, Inc. (ESPR) Q4 2025 Earnings Call Transcript...

Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates

Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates

8:16 10-03-2026

Esperion Therapeutics (ESPR) came out with quarterly earnings of $0.22 per share, missing the Zacks ...

Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

6:00 10-03-2026

– FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to...

ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M

ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M

11:40 04-03-2026

Esperion to buy Corstasis for $75M in cash, adding FDA-approved Enbumyst nasal spray to its cardiova...

Esperion Therapeutics, Inc. (ESPR) M&A Call Transcript

Esperion Therapeutics, Inc. (ESPR) M&A Call Transcript

17:22 03-03-2026

Esperion Therapeutics, Inc. (ESPR) M&A Call Transcript...

close

ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

11-02-2026
ANN ARBOR, MICH., FEB. 11, 2026 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT ON ...
Více zde

ESPERION PROVIDES BUSINESS UPDATE AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

11-01-2026
– REPORTS $156 TO $160 MILLION IN PRELIMINARY* FULL-YEAR 2025 U.S. NET PRODUCT SALES, A 35% TO 38%...
Více zde

ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-12-2025
ANN ARBOR, MICH., DEC. 09, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT ON ...
Více zde

ESPERION PARTNER HLS THERAPEUTICS ANNOUNCES APPROVAL OF NILEMDO® FOR THE REDUCTION OF LDL-CHOLESTEROL IN CANADIANS AT RISK OF CARDIOVASCULAR DISEASE

18-11-2025
ANN ARBOR, MICH., NOV. 18, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT HLS...
Více zde

ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-11-2025
ANN ARBOR, MICH., NOV. 06, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT ON ...
Více zde

ESPERION APPOINTS INDUSTRY VETERAN JOHN HARLOW AS CHIEF COMMERCIAL OFFICER

04-11-2025
– BRINGS EXTENSIVE EXECUTIVE LEADERSHIP DRIVING COMMERCIAL STRATEGIES THAT ENHANCE SALES AND MARKE...
Více zde

ESPERION ANNOUNCES NEW ANALYSES FROM CLEAR OUTCOMES TO BE PRESENTED AT THE AMERICAN HEART ASSOCIATION (AHA) SCIENTIFIC SESSIONS 2025

27-10-2025
ANN ARBOR, MICH., OCT. 27, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT AN ...
Více zde

ESPERION ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

07-10-2025
ANN ARBOR, MICH., OCT. 07, 2025 (GLOBE NEWSWIRE) -- ESPERION THERAPEUTICS, INC. (“ESPERION”) (NA...
Více zde

ESPERION ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

07-10-2025
ANN ARBOR, MICH., OCT. 07, 2025 (GLOBE NEWSWIRE) -- ESPERION THERAPEUTICS, INC. (“ESPERION”) (NA...
Více zde

ESPERION REACHES SETTLEMENT AGREEMENT WITH ANDA FILER, DR. REDDY'S LABORATORIES, NOT TO MARKET GENERIC VERSIONS OF NEXLETOL® (BEMPEDOIC ACID) AND NEXLIZET® (BEMPEDOIC ACID AND EZETIMIBE) PRIOR TO APRIL 19, 2040

03-10-2025
ANN ARBOR, MICH., OCT. 03, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT IT ...
Více zde

ESPERION PARTNER OTSUKA RECEIVES REGULATORY APPROVAL TO MARKET NEXLETOL® IN JAPAN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA

19-09-2025
THIRD LARGEST GLOBAL MARKET FOR CARDIOVASCULAR PREVENTION REPRESENTS SIGNIFICANT GLOBAL GROWTH OPPOR...
Více zde

ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-08-2025
ANN ARBOR, MICH., AUG. 07, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT ON ...
Více zde

ESPERION REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

05-08-2025
– Q2 2025 TOTAL REVENUE GREW 12% Y/Y TO $82.4 MILLION – – Q2 2025 U.S. NET PRODUCT REVENUE GRE...
Více zde

ESPERION TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 5

22-07-2025
ANN ARBOR, MICH., JULY 22, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED IT WILL ...
Více zde

ESPERION APPOINTS CRAIG THOMPSON TO BOARD OF DIRECTORS

01-07-2025
BRINGS MORE THAN TWENTY YEARS OF BIOPHARMACEUTICAL LEADERSHIP EXPERIENCE BRINGS MORE THAN TWENTY YEA...
Více zde

ESPERION REACHES SETTLEMENT AGREEMENT WITH ANDA FILER NOT TO MARKET GENERIC VERSION OF NEXLETOL® (BEMPEDOIC ACID) PRIOR TO APRIL 19, 2040

12-05-2025
ANN ARBOR, MICH., MAY 12, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT IT H...
Více zde

ESPERION TO PARTICIPATE IN H.C. WAINWRIGHT'S 3RD ANNUAL BIOCONNECT INVESTOR CONFERENCE

09-05-2025
ANN ARBOR, MICH., MAY 09, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT THE ...
Více zde

ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

08-05-2025
ANN ARBOR, MICH., MAY 08, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT ON M...
Více zde

ESPERION PARTNERS WITH HLS THERAPEUTICS TO COMMERCIALIZE NEXLETOL® (BEMPEDOIC ACID) AND NEXLIZET® (BEMPEDOIC ACID AND EZETIMIBE) IN CANADA

08-05-2025
– ESPERION TO RECEIVE AN UPFRONT PAYMENT, NEAR-TERM MILESTONES AND TIERED ROYALTIES ON PRODUCT SAL...
Více zde

ESPERION TO PARTICIPATE IN THE CITIZENS LIFE SCIENCES CONFERENCE

25-04-2025
ANN ARBOR, MICH., APRIL 25, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT TH...
Více zde

ESPERION TO HOST R&D DAY TO HIGHLIGHT CARDIOMETABOLIC PIPELINE INNOVATION AND NEXT-GENERATION THERAPEUTICS ON APRIL 24, 2025

10-04-2025
HIGHLIGHTING NOVEL INSIGHTS INTO ATP CITRATE LYASE (ACLY) BIOLOGY AND ITS THERAPEUTIC POTENTIAL IN M...
Více zde

ESPERION APPOINTS ROBERT E. HOFFMAN TO BOARD OF DIRECTORS

01-04-2025
- VETERAN INDUSTRY EXECUTIVE BRINGS DECADES OF FINANCIAL AND LEADERSHIP EXPERIENCE - ANN ARBOR, MICH...
Více zde

ESPERION REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

04-03-2025
– FY24 TOTAL REVENUE GREW 186% Y/Y TO $332.3 MILLION; FY24 U.S. NET PRODUCT REVENUE GREW 48% Y/Y T...
Více zde

ESPERION PARTNERS WITH CSL SEQIRUS TO COMMERCIALIZE NEXLETOL® (BEMPEDOIC ACID) AND NEXLIZET® (BEMPEDOIC ACID AND EZETIMIBE) IN AUSTRALIA

03-03-2025
– ESPERION TO RECEIVE AN UPFRONT PAYMENT AND NEAR-TERM MILESTONES ALONG WITH A PROFITABLE TRANSFER...
Více zde

ESPERION TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON MARCH 4

18-02-2025
ANN ARBOR, MICH., FEB. 18, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED IT WILL ...
Více zde

ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

13-02-2025
ANN ARBOR, MICH., FEB. 13, 2025 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR) TODAY ANNOUNCED THAT ON ...
Více zde

ESPERION STRENGTHENS BALANCE SHEET WITH CLOSING OF SIGNIFICANT REFINANCING TRANSACTIONS

18-12-2024
– $150 MILLION SENIOR SECURED TERM LOAN CREDIT FACILITY AND NEW $100 MILLION CONVERTIBLE NOTE TO R...
Více zde

ESPERION ANNOUNCES $210 MILLION CONVERTIBLE DEBT FINANCING

13-12-2024
ANN ARBOR, MICH., DEC. 13, 2024 (GLOBE NEWSWIRE) -- ESPERION (THE “COMPANY”) (NASDAQ: ESPR) TODA...
Více zde

ESPERION PARTNERS WITH NEOPHARM TO COMMERCIALIZE NEXLETOL® (BEMPEDOIC ACID) AND NEXLIZET® (BEMPEDOIC ACID AND EZETIMIBE) IN ISRAEL

12-12-2024
– ESPERION TO RECEIVE AN UPFRONT PAYMENT AND NEAR-TERM MILESTONES ALONG WITH TIERED ROYALTIES ON P...
Více zde

ESPERION HIGHLIGHTS NEW EXPLORATORY DATA FROM CLEAR OUTCOMES TRIAL HIGHLIGHTING VALUE OF NEXLETOL® (BEMPEDOIC ACID) IN ORAL FEATURED SCIENCE SESSION AND MULTIPLE POSTER PRESENTATIONS AT AHA SCIENTIFIC SESSIONS 2024

18-11-2024
– AN EXPLORATORY ANALYSIS REPORTS PATIENTS WITH PAD WHO TOOK BEMPEDOIC ACID WERE 36% LESS LIKELY T...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-11-04 00:00:008-KStáhnout
2025-10-08 01:00:008-KStáhnout
2025-10-08 00:00:008-KStáhnout
2025-10-07 01:00:008-KStáhnout
2025-10-07 00:00:008-KStáhnout
2025-08-13 01:00:0010-QStáhnout
2025-08-13 00:00:0010-QStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 00:00:008-KStáhnout
2025-07-01 01:00:008-KStáhnout
2025-07-01 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 00:00:008-KStáhnout
2025-04-04 01:00:008-KStáhnout
2025-04-04 00:00:008-KStáhnout
2025-04-01 01:00:008-KStáhnout
2025-04-01 00:00:008-KStáhnout
2025-03-07 00:00:0010-KStáhnout
2025-03-06 23:00:0010-KStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-03 23:00:008-KStáhnout
2025-01-16 00:00:008-KStáhnout
2025-01-15 23:00:008-KStáhnout
2024-12-18 00:00:008-KStáhnout
2024-12-17 23:00:008-KStáhnout
2024-12-13 00:00:008-KStáhnout
2024-12-12 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-08-12 01:00:008-KStáhnout
2024-08-12 01:00:0010-QStáhnout
2024-08-12 00:00:008-KStáhnout
2024-08-12 00:00:0010-QStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 00:00:008-KStáhnout
2024-06-28 01:00:008-KStáhnout
2024-06-28 00:00:008-KStáhnout
2024-05-28 01:00:008-KStáhnout
2024-05-28 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-01-22 00:00:008-KStáhnout
2024-01-21 23:00:008-KStáhnout
2024-01-18 00:00:008-KStáhnout
2024-01-17 23:00:008-KStáhnout
2024-01-11 00:00:008-KStáhnout
2024-01-10 23:00:008-KStáhnout
2024-01-03 00:00:008-KStáhnout
2024-01-02 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-08-01 01:00:008-KStáhnout
2023-08-01 01:00:0010-QStáhnout
2023-08-01 00:00:008-KStáhnout
2023-08-01 00:00:0010-QStáhnout
2023-06-26 01:00:008-KStáhnout
2023-06-26 00:00:008-KStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 00:00:008-KStáhnout
2023-03-27 01:00:008-KStáhnout
2023-03-27 00:00:008-KStáhnout
2023-03-22 00:00:008-KStáhnout
2023-03-21 23:00:008-KStáhnout
2023-03-15 00:00:008-KStáhnout
2023-03-14 23:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-02-21 00:00:008-KStáhnout
2023-02-21 00:00:0010-KStáhnout
2023-02-20 23:00:008-KStáhnout
2023-02-20 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-23 00:00:008-KStáhnout
2022-11-22 23:00:008-KStáhnout
2022-11-16 00:00:008-KStáhnout
2022-11-15 23:00:008-KStáhnout
2022-11-01 00:00:008-KStáhnout
2022-11-01 00:00:0010-QStáhnout
2022-10-31 23:00:008-KStáhnout
2022-10-31 23:00:0010-QStáhnout
2022-09-20 01:00:008-KStáhnout
2022-09-20 00:00:008-KStáhnout
2022-08-02 01:00:008-KStáhnout
2022-08-02 01:00:0010-QStáhnout
2022-08-02 00:00:008-KStáhnout
2022-08-02 00:00:0010-QStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-06-01 01:00:008-KStáhnout
2022-06-01 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-03 01:00:008-KStáhnout
2022-05-03 01:00:0010-QStáhnout
2022-05-03 00:00:008-KStáhnout
2022-05-03 00:00:0010-QStáhnout
2022-04-28 01:00:008-KStáhnout
2022-04-28 00:00:008-KStáhnout
2022-03-15 00:00:008-KStáhnout
2022-03-14 23:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-22 00:00:0010-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-02-21 23:00:0010-KStáhnout
2022-01-11 00:00:008-KStáhnout
2022-01-10 23:00:008-KStáhnout
2022-01-04 00:00:008-KStáhnout
2022-01-03 23:00:008-KStáhnout
2021-12-07 00:00:008-KStáhnout
2021-12-06 23:00:008-KStáhnout
2021-11-02 00:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:008-KStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-10-25 01:00:008-KStáhnout
2021-10-25 00:00:008-KStáhnout
2021-10-18 01:00:008-KStáhnout
2021-10-18 00:00:008-KStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 01:00:0010-QStáhnout
2021-08-03 00:00:008-KStáhnout
2021-08-03 00:00:0010-QStáhnout
2021-06-28 01:00:008-KStáhnout
2021-06-28 00:00:008-KStáhnout
2021-05-28 01:00:008-KStáhnout
2021-05-28 00:00:008-KStáhnout
2021-05-17 01:00:008-KStáhnout
2021-05-17 00:00:008-KStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:008-KStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-04-26 01:00:008-KStáhnout
2021-04-26 00:00:008-KStáhnout
2021-02-23 00:00:008-KStáhnout
2021-02-23 00:00:0010-KStáhnout
2021-02-22 23:00:008-KStáhnout
2021-02-22 23:00:0010-KStáhnout
2021-01-13 00:00:008-KStáhnout
2021-01-12 23:00:008-KStáhnout
2020-12-16 00:00:008-KStáhnout
2020-12-15 23:00:008-KStáhnout
2020-12-15 00:00:008-KStáhnout
2020-12-14 23:00:008-KStáhnout
2020-11-16 00:00:008-KStáhnout
2020-11-15 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-02 00:00:008-KStáhnout
2020-11-02 00:00:0010-QStáhnout
2020-11-01 23:00:008-KStáhnout
2020-11-01 23:00:0010-QStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-06-22 01:00:008-KStáhnout
2020-06-22 00:00:008-KStáhnout
2020-05-29 01:00:008-KStáhnout
2020-05-29 00:00:008-KStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 01:00:0010-QStáhnout
2020-05-06 00:00:008-KStáhnout
2020-05-06 00:00:0010-QStáhnout
2020-04-20 01:00:008-KStáhnout
2020-04-20 00:00:008-KStáhnout
2020-04-09 01:00:008-KStáhnout
2020-04-09 00:00:008-KStáhnout
2020-04-06 01:00:008-KStáhnout
2020-04-06 00:00:008-KStáhnout
2020-03-18 00:00:008-KStáhnout
2020-03-17 23:00:008-KStáhnout
2020-02-27 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:008-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-02-21 00:00:008-KStáhnout
2020-02-20 23:00:008-KStáhnout
2020-01-31 00:00:008-KStáhnout
2020-01-30 23:00:008-KStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-06 00:00:0010-QStáhnout
2019-11-05 23:00:008-KStáhnout
2019-11-05 23:00:0010-QStáhnout
2019-08-29 01:00:008-KStáhnout
2019-08-29 00:00:008-KStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 01:00:0010-QStáhnout
2019-08-08 00:00:008-KStáhnout
2019-08-08 00:00:0010-QStáhnout
2019-06-26 01:00:008-KStáhnout
2019-06-26 00:00:008-KStáhnout
2019-05-30 01:00:008-KStáhnout
2019-05-30 00:00:008-KStáhnout
2019-05-08 01:00:008-KStáhnout
2019-05-08 01:00:0010-QStáhnout
2019-05-08 00:00:008-KStáhnout
2019-05-08 00:00:0010-QStáhnout
2019-05-06 01:00:008-KStáhnout
2019-05-06 00:00:008-KStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-28 00:00:0010-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-02-27 23:00:0010-KStáhnout
2019-01-04 00:00:008-KStáhnout
2019-01-03 23:00:008-KStáhnout
2018-12-21 00:00:008-KStáhnout
2018-12-20 23:00:008-KStáhnout
2018-11-01 00:00:008-KStáhnout
2018-11-01 00:00:0010-QStáhnout
2018-10-31 23:00:008-KStáhnout
2018-10-31 23:00:0010-QStáhnout
2018-10-29 00:00:008-KStáhnout
2018-10-28 23:00:008-KStáhnout
2018-08-27 01:00:008-KStáhnout
2018-08-27 00:00:008-KStáhnout
2018-08-02 01:00:008-KStáhnout
2018-08-02 01:00:0010-QStáhnout
2018-08-02 00:00:008-KStáhnout
2018-08-02 00:00:0010-QStáhnout
2018-05-29 01:00:008-KStáhnout
2018-05-29 00:00:008-KStáhnout
2018-05-23 01:00:008-KStáhnout
2018-05-23 00:00:008-KStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 00:00:008-KStáhnout
2018-05-02 01:00:008-KStáhnout
2018-05-02 01:00:0010-QStáhnout
2018-05-02 00:00:008-KStáhnout
2018-05-02 00:00:0010-QStáhnout
2018-03-27 01:00:008-KStáhnout
2018-03-27 00:00:008-KStáhnout
2018-03-07 00:00:008-KStáhnout
2018-03-06 23:00:008-KStáhnout
2018-02-20 00:00:008-KStáhnout
2018-02-20 00:00:0010-KStáhnout
2018-02-19 23:00:008-KStáhnout
2018-02-19 23:00:0010-KStáhnout
2017-12-14 00:00:008-KStáhnout
2017-12-13 23:00:008-KStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:008-KStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-11-06 00:00:008-KStáhnout
2017-11-05 23:00:008-KStáhnout
2017-08-10 01:00:008-KStáhnout
2017-08-10 00:00:008-KStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-07-27 01:00:008-KStáhnout
2017-07-27 00:00:008-KStáhnout
2017-06-26 01:00:008-KStáhnout
2017-06-26 00:00:008-KStáhnout
2017-05-04 01:00:008-KStáhnout
2017-05-04 01:00:0010-QStáhnout
2017-05-04 00:00:008-KStáhnout
2017-05-04 00:00:0010-QStáhnout
2017-04-20 01:00:008-KStáhnout
2017-04-20 00:00:008-KStáhnout
2017-03-20 00:00:008-KStáhnout
2017-03-19 23:00:008-KStáhnout
2017-03-07 00:00:008-KStáhnout
2017-03-06 23:00:008-KStáhnout
2017-02-22 00:00:008-KStáhnout
2017-02-22 00:00:0010-KStáhnout
2017-02-21 23:00:008-KStáhnout
2017-02-21 23:00:0010-KStáhnout
2017-01-09 00:00:008-KStáhnout
2017-01-08 23:00:008-KStáhnout
2016-12-09 00:00:008-KStáhnout
2016-12-08 23:00:008-KStáhnout
2016-11-03 00:00:008-KStáhnout
2016-11-03 00:00:0010-QStáhnout
2016-11-02 23:00:008-KStáhnout
2016-11-02 23:00:0010-QStáhnout
2016-10-13 01:00:008-KStáhnout
2016-10-13 00:00:008-KStáhnout
2016-08-04 01:00:008-KStáhnout
2016-08-04 01:00:0010-QStáhnout
2016-08-04 00:00:008-KStáhnout
2016-08-04 00:00:0010-QStáhnout
2016-06-28 01:00:008-KStáhnout
2016-06-28 00:00:008-KStáhnout
2016-06-15 01:00:008-KStáhnout
2016-06-15 00:00:008-KStáhnout
2016-05-04 01:00:008-KStáhnout
2016-05-04 01:00:0010-QStáhnout
2016-05-04 00:00:008-KStáhnout
2016-05-04 00:00:0010-QStáhnout
2016-02-25 00:00:008-KStáhnout
2016-02-25 00:00:0010-KStáhnout
2016-02-24 23:00:008-KStáhnout
2016-02-24 23:00:0010-KStáhnout
2016-01-12 00:00:008-KStáhnout
2016-01-11 23:00:008-KStáhnout
2015-12-03 00:00:008-KStáhnout
2015-12-02 23:00:008-KStáhnout
2015-11-05 00:00:008-KStáhnout
2015-11-05 00:00:0010-QStáhnout
2015-11-04 23:00:008-KStáhnout
2015-11-04 23:00:0010-QStáhnout
2015-09-28 01:00:008-KStáhnout
2015-09-28 00:00:008-KStáhnout
2015-08-17 01:00:008-KStáhnout
2015-08-17 00:00:008-KStáhnout
2015-08-06 01:00:008-KStáhnout
2015-08-06 01:00:0010-QStáhnout
2015-08-06 00:00:008-KStáhnout
2015-08-06 00:00:0010-QStáhnout
2015-07-28 01:00:008-KStáhnout
2015-07-28 00:00:008-KStáhnout
2015-07-07 01:00:008-KStáhnout
2015-07-07 00:00:008-KStáhnout
2015-06-15 01:00:008-KStáhnout
2015-06-15 00:00:008-KStáhnout
2015-05-20 01:00:008-KStáhnout
2015-05-20 00:00:008-KStáhnout
2015-05-07 01:00:008-KStáhnout
2015-05-07 01:00:0010-QStáhnout
2015-05-07 00:00:008-KStáhnout
2015-05-07 00:00:0010-QStáhnout
2015-03-19 00:00:008-KStáhnout
2015-03-18 23:00:008-KStáhnout
2015-03-17 00:00:008-KStáhnout
2015-03-16 23:00:008-KStáhnout
2015-03-10 00:00:0010-KStáhnout
2015-03-09 23:00:0010-KStáhnout
2015-03-05 00:00:008-KStáhnout
2015-03-04 23:00:008-KStáhnout
2015-02-02 00:00:008-KStáhnout
2015-02-01 23:00:008-KStáhnout
2015-01-12 00:00:008-KStáhnout
2015-01-11 23:00:008-KStáhnout
2014-11-10 00:00:008-KStáhnout
2014-11-10 00:00:0010-QStáhnout
2014-11-09 23:00:008-KStáhnout
2014-11-09 23:00:0010-QStáhnout
2014-10-16 01:00:008-KStáhnout
2014-10-16 00:00:008-KStáhnout
2014-10-14 01:00:008-KStáhnout
2014-10-14 00:00:008-KStáhnout
2014-10-01 01:00:008-KStáhnout
2014-10-01 00:00:008-KStáhnout
2014-08-12 01:00:008-KStáhnout
2014-08-12 01:00:0010-QStáhnout
2014-08-12 00:00:008-KStáhnout
2014-08-12 00:00:0010-QStáhnout
2014-07-31 01:00:008-KStáhnout
2014-07-31 00:00:008-KStáhnout
2014-07-24 01:00:008-KStáhnout
2014-07-24 00:00:008-KStáhnout
2014-07-02 01:00:008-KStáhnout
2014-07-02 00:00:008-KStáhnout
2014-06-26 01:00:008-KStáhnout
2014-06-26 00:00:008-KStáhnout
2014-05-19 01:00:008-KStáhnout
2014-05-19 00:00:008-KStáhnout
2014-05-12 01:00:008-KStáhnout
2014-05-12 01:00:0010-QStáhnout
2014-05-12 00:00:008-KStáhnout
2014-05-12 00:00:0010-QStáhnout
2014-03-13 00:00:0010-KStáhnout
2014-03-12 23:00:0010-KStáhnout
2014-03-07 00:00:008-KStáhnout
2014-03-06 23:00:008-KStáhnout
2014-02-28 00:00:008-KStáhnout
2014-02-27 23:00:008-KStáhnout
2014-02-14 00:00:008-KStáhnout
2014-02-13 23:00:008-KStáhnout
2014-02-07 00:00:008-KStáhnout
2014-02-06 23:00:008-KStáhnout
2014-01-13 00:00:008-KStáhnout
2014-01-12 23:00:008-KStáhnout
2013-11-22 00:00:008-KStáhnout
2013-11-21 23:00:008-KStáhnout
2013-11-06 00:00:008-KStáhnout
2013-11-06 00:00:0010-QStáhnout
2013-11-05 23:00:008-KStáhnout
2013-11-05 23:00:0010-QStáhnout
2013-10-30 00:00:008-KStáhnout
2013-10-29 23:00:008-KStáhnout
2013-09-03 01:00:008-KStáhnout
2013-09-03 00:00:008-KStáhnout
2013-08-27 01:00:008-KStáhnout
2013-08-27 00:00:008-KStáhnout
2013-08-12 01:00:008-KStáhnout
2013-08-12 01:00:0010-QStáhnout
2013-08-12 00:00:008-KStáhnout
2013-08-12 00:00:0010-QStáhnout
preloader